What Is The Radiant Bundle?

Overview

The Anti-Inflammation Stack groups three peptides that are each independently characterized in the preclinical literature as modulators of inflammatory signalling and tissue repair. It is supplied as six separate vials, so the material corresponds to three distinct bodies of published work rather than to a single studied formulation.

KPV is the C-terminal tripeptide of α-melanocyte-stimulating hormone. Brzoska and colleagues reviewed this peptide family as anti-inflammatory and protective agents in vitro and in vivo, and Dalmasso et al. reported that KPV is taken up through the PepT1 transporter and reduced intestinal inflammation in murine models.[14][15] Kelly et al. reported that immobilized GKPV inhibited TNF-α-stimulated NF-κB activity.[17]

TB-500 is the N-acetylated 17–23 fragment of Thymosin β4, an identity confirmed analytically by Esposito et al.[7] The LKKTETQ actin-binding motif it carries has been described by Sosne et al. as an active site of the parent protein, and Philp et al. reported that a synthetic peptide containing this domain promoted dermal wound repair in rodent models.[12][13]

BPC-157 is a synthetic pentadecapeptide derived from a sequence identified in gastric juice by Sikiric and colleagues, whose group developed the cytoprotection framework that organizes most of its literature.[1][2] Hsieh et al. associated its pro-angiogenic activity with VEGFR2 activation.[3]

No peer-reviewed study has evaluated these three peptides together as a stack. Every citation on this page describes an individual component tested on its own. Investigators should treat the kit as three separate research materials and refer to the dedicated KPV, TB-500, and BPC-157 entries for complete mechanism, applications, and reference lists.